Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1948 1
1950 3
1951 4
1954 2
1955 2
1956 3
1958 1
1960 1
1962 1
1964 1
1965 3
1966 7
1967 3
1968 4
1969 4
1970 7
1971 6
1972 3
1973 5
1974 5
1975 3
1977 3
1978 1
1979 2
1980 3
1981 3
1982 3
1983 4
1984 2
1985 2
1986 3
1987 11
1988 10
1989 14
1990 16
1991 9
1992 19
1993 12
1994 28
1995 15
1996 15
1997 23
1998 54
1999 80
2000 70
2001 70
2002 98
2003 107
2004 113
2005 160
2006 176
2007 171
2008 147
2009 152
2010 151
2011 197
2012 207
2013 226
2014 311
2015 380
2016 419
2017 481
2018 633
2019 680
2020 842
2021 1043
2022 1093
2023 1215
2024 459

Text availability

Article attribute

Article type

Publication date

Search Results

8,817 results

Results by year

Filters applied: . Clear all
The following term was not found in PubMed: Borromeo-Ferri
Page 1
Rita Levi-Montalcini: the neurologist who challenged fascism.
Coutinho L, Teive HAG. Coutinho L, et al. Arq Neuropsiquiatr. 2023 Jan;81(1):95-98. doi: 10.1055/s-0043-1761426. Epub 2023 Mar 14. Arq Neuropsiquiatr. 2023. PMID: 36918012 Free PMC article. Review.
Rita Levi-Montalcini was a researcher in the field of neuroscience, Italian and Jewish in origin, who discovered the nerve growth factor and rightfully earned the 1986 Nobel Prize in Physiology or Medicine, alongside her collaborator Stanley Cohen. ...Despite these obstacl …
Rita Levi-Montalcini was a researcher in the field of neuroscience, Italian and Jewish in origin, who discovered the nerve growth fac …
Why Are We Scientists? Drawing Inspiration From Rita Levi-Montalcini.
Malerba F. Malerba F. Front Cell Neurosci. 2022 Jan 21;15:741984. doi: 10.3389/fncel.2021.741984. eCollection 2021. Front Cell Neurosci. 2022. PMID: 35126056 Free PMC article. Review.
In 2007, drawing inspiration from her previous experiments on chick embryos, Rita Levi-Montalcini, at the age of 98, proposed a new project, and a research group, in which I was included, was formed at the European Brain Research Institute (EBRI). ...This approach has alwa …
In 2007, drawing inspiration from her previous experiments on chick embryos, Rita Levi-Montalcini, at the age of 98, proposed a new p …
The radial artery: a forgotten conduit.
Gaudino M, Crea F, Cammertoni F, Massetti M. Gaudino M, et al. Ann Thorac Surg. 2015 Apr;99(4):1479-85. doi: 10.1016/j.athoracsur.2014.11.045. Epub 2015 Feb 26. Ann Thorac Surg. 2015. PMID: 25725926 Review.
The RA is a better graft than the saphenous vein and comparable to the right internal thoracic artery (RITA); moreover, the RA seems a better choice than the RITA in patients at risk of sternal or pulmonary complications. We conclude that the RA should be preferred …
The RA is a better graft than the saphenous vein and comparable to the right internal thoracic artery (RITA); moreover, the RA seems …
Long-Term Results of the RAPCO Trials.
Buxton BF, Hayward PA, Raman J, Moten SC, Rosalion A, Gordon I, Seevanayagam S, Matalanis G, Benedetto U, Gaudino M, Hare DL; RAPCO Investigators*. Buxton BF, et al. Circulation. 2020 Oct 6;142(14):1330-1338. doi: 10.1161/CIRCULATIONAHA.119.045427. Epub 2020 Oct 5. Circulation. 2020. PMID: 33017209 Clinical Trial.
The RAPCO trials (Radial Artery Patency and Clinical Outcomes) were designed to compare the long-term patency of the radial artery (RA) with that of the right internal thoracic artery (RITA) and the saphenous vein (SV). METHODS: In RAPCO-RITA (the RITA versus …
The RAPCO trials (Radial Artery Patency and Clinical Outcomes) were designed to compare the long-term patency of the radial artery (RA) with …
Chk2 mediates RITA-induced apoptosis.
de Lange J, Verlaan-de Vries M, Teunisse AF, Jochemsen AG. de Lange J, et al. Cell Death Differ. 2012 Jun;19(6):980-9. doi: 10.1038/cdd.2011.182. Epub 2011 Dec 9. Cell Death Differ. 2012. PMID: 22158418 Free PMC article.
In addition, we observed an early p53- and Chk2-dependent block of DNA replication upon RITA treatment. Replicating cells seemed more prone to entering RITA-induced apoptosis. ...In conclusion, we identified Chk2 as an essential mediator of the cellular responses to …
In addition, we observed an early p53- and Chk2-dependent block of DNA replication upon RITA treatment. Replicating cells seemed more …
Bilateral internal thoracic artery grafting: in situ or composite?
Kawajiri H, Grau JB, Fortier JH, Glineur D. Kawajiri H, et al. Ann Cardiothorac Surg. 2018 Sep;7(5):673-680. doi: 10.21037/acs.2018.05.16. Ann Cardiothorac Surg. 2018. PMID: 30505752 Free PMC article.
Composite BITA grafting is the other option that maximizes right ITA (RITA) utilization. In this configuration, the RITA is able to reach the distal circumflex and right coronary artery branches. ...
Composite BITA grafting is the other option that maximizes right ITA (RITA) utilization. In this configuration, the RITA is ab …
RITA outcomes.
Jones E. Jones E. Br Dent J. 2006 Mar 25;200(6):303. doi: 10.1038/sj.bdj.4813379. Br Dent J. 2006. PMID: 16568036 No abstract available.
Decreased DNA Damage and Improved p53 Specificity of RITA Analogs.
Zhan Y, Zhou X, Peuget S, Singh M, Peyser BD, Fan Z, Selivanova G. Zhan Y, et al. Mol Cancer Ther. 2022 Oct 7;21(10):1524-1534. doi: 10.1158/1535-7163.MCT-22-0119. Mol Cancer Ther. 2022. PMID: 35877475 Free PMC article.
Several synthetic modifications to RITA's heterocyclic scaffold lead to higher energy barriers for carbocation formation. In this study, we addressed the question whether RITA analogs NSC777196 and NSC782846 can induce p53-dependent apoptosis without SULT1A1-depende …
Several synthetic modifications to RITA's heterocyclic scaffold lead to higher energy barriers for carbocation formation. In this stu …
The right internal thoracic artery: is it underutilized?
Tatoulis J, Buxton BF, Fuller JA. Tatoulis J, et al. Curr Opin Cardiol. 2011 Nov;26(6):528-35. doi: 10.1097/HCO.0b013e32834b9f87. Curr Opin Cardiol. 2011. PMID: 21918432 Review.
RECENT FINDINGS: RITA use is 4% in the USA, and 10% in the UK and Australia, although higher in some centres. ...SUMMARY: As evidence of excellent RITA results increases, strategies are required to encourage its use. ...
RECENT FINDINGS: RITA use is 4% in the USA, and 10% in the UK and Australia, although higher in some centres. ...SUMMARY: As evidence …
8,817 results